Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore

• Main Authors: Phua, LC, Choi, HCW, Wu, J, Jit, M, Low, J, Ng, K, Pearce, F, Hall, C, Abdul Aziz, MI
• Other Authors: DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
• Format: Article
• Published: Elsevier BV 2021
• Subjects: Bivalent vaccine; Cervical cancer; Cost-effectiveness; Human papillomavirus; Nonavalent vaccine; Transmission dynamic model; Adolescent; Cost-Benefit Analysis; Female; Humans; Papillomavirus Infections; Papillomavirus Vaccines; Quality-Adjusted Life Years; Singapore; Uterine Cervical Neoplasms; Vaccination
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/206124
• Institution: National University of Singapore

10.1016/j.vaccine.2021.03.040